Hyperventilation Syndrome
12
1
1
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
8.3%
1 terminated out of 12 trials
88.9%
+2.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
Impact of Respiratory Rehabilitation on Quality of Life in Patients With Hyperventilation Syndrome
Hyperventilation in Patients With Chronic Low Back Pain
Relationship Between Hyperventilation Syndrome and SARS-CoV-2 Infection
Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise
Work Productivity in Hyperventilation Syndrome
Predictive Properties of the Hyperventilation Provocation Test for the Diagnosis of the Hyperventilation Syndrome
Ventilatory Responses to Hypercapnic and Hypoxic Conditions in Hyperventilants
Turkish Version of Nijmegen Questionnaire
Dysfunctional Breathing: Characterisation and Assessment
Comparison of Transcutaneous Vs End-tidal CO2 Pressure Measurements in Hyperventilation Syndrome Diagnosis
Nasal Ventilation Versus Voluntary Hypoventilation in the Rehabilitation of Hyperventilation Syndrome
Prevalence of Hyperventilation Syndrome in Difficult Asthma